Pfizer PFE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | $9.87B— | $10.79B— | $7.91B— | ||
| $6.59B-4.5% | $6.59B-6.0% | $6.7B-2.8% | $6.79B+1.4% | $6.89B+5.4% | ||
| $901M+8.9% | $799M-8.9% | $751M-8.5% | $824M+18.1% | $827M+29.2% | ||
| $12.57B-10.2% | $12.29B-3.6% | $13.66B+21.3% | $15.77B+97.0% | $13.99B— | ||
| $2.5B-9.7% | $2.63B-9.6% | $2.7B-11.0% | $2.75B-13.9% | $2.77B-20.2% | ||
| -$3.84B— | -$1.35B— | —— | —— | —— | ||
| -$8.53B+51.1% | -$10.9B+36.4% | -$16.01B-143% | -$18.17B— | -$17.44B— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pfizer generate?
- Pfizer (PFE) generated $12.6B in operating cash flow over the trailing twelve months.
- What is Pfizer's free cash flow?
- After $2.5B of capital expenditures, Pfizer's free cash flow was $12.5B over the trailing twelve months, up 26.6% year over year.
- Where does Pfizer's cash flow data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
